Clinical Trial Update: Analgesia in Inguinal Hernia Repair Using a Cyclooxygenase-2-specific Inhibitor [NA]

View source ↗

Summary

A completed clinical trial evaluated a cyclooxygenase-2–specific inhibitor for analgesia in inguinal hernia repair.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inguinal Hernia

Drugs mentioned

• Cyclooxygenase-2-specific inhibitor

Snippet

Sponsor: Bnai Zion Medical Center | Conditions: Adverse Anesthesia Outcome | NA | Status: COMPLETED